In conclusion, hs-cTn-I is a potential biomarker for evaluating long-term prognosis in idiopathic DCM, and its predictive value is higher than that of BNP in patients with preserved renal function. This evidence concerns the gene TNNI3 and familial dilated cardiomyopathy.